In the News
ICON experts frequently author or contribute to industry trade press.
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category.
-
The Danger of 'Going too far' with AI
Andrew Garrett spoke on a panel at the Financial Times Pharmaceutical & Biotechnology conference, about the recent integration of artificial intelligence (AI) enabled services in pharma R&D.
-
Risk-Based Monitoring and Real-World Data: A Decentralised Ecosystem
Ian O'Shaughnessy considers how to ensure a reality for the bright future of digitisation as clinical trials evolve.
-
Trends in Payer Reliance on ICER Assessments
A thought leadership authored by Jenny Lee and Eric Latch, based on the ICON’s whitepaper regarding payer reliance on ICER assessments and perceptions on value-based pricing.
-
A Strategic Business Plan to ensure success under MDR/IVDR
David Novotny and Angela Brown share their insights in this Medical Design and Outsourcing article as to how manufacturers can develop a strategic business model that will prepare them for success under the new MDR/IVDR reforms
-
-
Trends in Biosimilar Market Access
A thought leadership article authored by Jenny Lee and Gene Chieh, investigating how biosimilars have gained momentum in a growing number of markets.
-
Biomarker-driven Landscape in Clinical Trials
ICON's Nicole Cowan is interviewed in the latest edition of Clinical OMICs about the new biomarker-driven landscape in clinical trials and the nuances of drug-diagnostics co-development programs.
-
Social Media Outreach
ICON expert Gretchen Goller considers social media outreach's beneficial effect on patient connectivity to date in the October 2019 edition of Pharma Voice.
-
Making it Easier for the Site to Succeed
A thought leadership article authored by EB McLindon, discussing how making clinical research easier for the site can also make life easier for sponsors.
-
